NF2 and meningioma: Integrating data from meningioma xenografts and patients, our results establish signaling pathways that underlie meningioma ADC as a potential imaging biomarker of Wnt signaling in Merlin-intact meningiomas with S13 phosphorylation and favorable clinical outcomes (Fig. 4g).